BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024

  TRACON Pharmaceuticals, Inc. announced that it will report its fourth quarter and year-end 2023 financial and operating results after the close of U.S. financial markets on Tuesday, March 5, 2024.

  February 28, 2024

   · 

  2 min read
• Genetown

  Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference

  Xilio Therapeutics, Inc. announced that René Russo, Pharm.D., president and chief executive officer, will participate in the “Novel Immuno-Oncology” panel discussion during the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024 at 10:30 am EST.

  February 28, 2024

   · 

  1 min read
• Business

  Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

  Voyager Therapeutics, Inc., a biotechnology company dedicated to advancing neurogenetic medicines, reported fourth quarter and full year 2023 financial and operating results.

  February 28, 2024

   · 

  18 min read
• Policy

  Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro

  Inhibikase Therapeutics, Inc. announced preliminary outcomes of the Company’s discussion with the U.S. Food and Drug Administration on the path to approval of IkT-001Pro in blood and stomach cancers, the Company’s prodrug of the anticancer agent imatinib mesylate.

  February 28, 2024

   · 

  6 min read
• Business

  Inari Medical Reports Fourth Quarter 2023 Financial Results

  Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, reported financial results for its fourth quarter and full year ended December 31, 2023.

  February 28, 2024

   · 

  13 min read
• Business

  Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

  Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023, and provided a business update.

  February 28, 2024

   · 

  19 min read
• BioMidwest

  Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026

  Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, introduced its Continued Growth Initiatives Program and related financial targets for the three-year period ending December 31, 2026.

  February 28, 2024

   · 

  11 min read
• Business

  Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

  Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today reported financial results for the fourth quarter and full year ended December 31, 2023.

  February 28, 2024

   · 

  12 min read
• Business

  Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023.

  February 28, 2024

   · 

  10 min read
• Business

  MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

  MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the fourth quarter and full year 2023.

  February 28, 2024

   · 

  20 min read